Feb 12 (Reuters) - Eli Lilly had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug, a ...

In fact, last year Lilly's medication -- called tirzepatide, which treats both type 2 diabetes and obesity -- became the best ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… ...

Eli Lilly and Company (NYSE:LLY) is included among 13 Best Long Term Low Risk Stocks to Buy Now. On February 5, Goldman Sachs ...

Novo Nordisk A/S aims to start selling its weight-loss blockbuster Wegovy in vials, its latest move to win over customers ...

Eli Lilly and Company (NYSE:LLY) executives highlighted strong 2025 performance, continued demand for its incretin medicines, ...

Drugmaker Eli Lilly and Co. says it'll build a $3.5 billion manufacturing facility in Pennsylvania, as the company expands ...

The City of Huntsville announced on Tuesday that the city council approved a development agreement to build an Eli Lilly and Company pharmaceutical manufacturing plant.

Mounjaro and Zepbound generated a combined $11.7 billion in sales for the company in its most recent quarter.

We came across a bullish thesis on Eli Lilly and Company on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company’s share was trading at ...

The investment supports Eli Lilly and Company’s $3.5 billion expansion into Upper Macungie Township, marking the largest private-sector investment in Lehigh Valley history.

Both companies are betting on interest in weight loss pills.